Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueGross ProfitShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025)

Creative Medical Technology Holdings has reported Gross Profit over the past 9 years, most recently at $2006.0 for Q4 2025.

  • Quarterly Gross Profit rose 11.44% to $2006.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3806.0 through Dec 2025, down 42.33% year-over-year, with the annual reading at $3806.0 for FY2025, 42.33% down from the prior year.
  • Gross Profit was $2006.0 for Q4 2025 at Creative Medical Technology Holdings, up from $1800.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $39000.0 in Q3 2022 and troughed at $1800.0 in Q4 2023.
  • The 5-year median for Gross Profit is $5150.0 (2021), against an average of $9643.3.
  • Biggest five-year swings in Gross Profit: soared 550.0% in 2022 and later plummeted 90.77% in 2023.
  • Tracing CELZ's Gross Profit over 5 years: stood at $28305.0 in 2021, then plummeted by 54.43% to $12900.0 in 2022, then crashed by 86.05% to $1800.0 in 2023, then changed by 0.0% to $1800.0 in 2024, then grew by 11.44% to $2006.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $2006.0, $1800.0, and $1800.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.